CD4 and lung carcinoma: A major limitation of our study is the number of HIV-positive patients, especially those with lung cancer, which do not permit the survival analysis in this subpopulation as well as the co-estimation with other parameters such as the counts of CD4(+) and CD(8)+ T cells.